POMDOCTOR LIMITED Unveils Comprehensive Revenue Diversification Strategy in Digital Healthcare

POMDOCTOR LIMITED, known as Pomdoctor and traded on NASDAQ under the symbol POM, has recently outlined its groundbreaking four-tier revenue structure aimed at redefining healthcare services and fostering growth within its operations. The company, which specializes in AI-enabled healthcare solutions, has emphasized its commitment to integrating technology with healthcare delivery to enhance patient outcomes.

Understanding the Four-Tier Revenue Structure

Pomdoctor's diversified revenue strategy consists of four main components, each designed to capitalize on the company's existing strengths while introducing innovative services:

1. B2C Basic Healthcare Services: This segment serves as the foundational pillar of Pomdoctor’s operations. The company utilizes an extensive internet hospital platform, encompassing a vast network of physicians and a robust supply chain for pharmaceuticals. This established framework facilitates various healthcare services, including online consultations and prescription delivery, ensuring seamless connectivity between patients and healthcare providers.

Recent reports indicate that Pomdoctor achieved net revenues of approximately RMB399.9 million (about USD 59.04 million) for the fiscal year 2025, a significant increase from the previous years, underscoring growth in its healthcare services.

2. AI-Enabled Chronic Disease Membership Subscriptions: Building on its core B2C offerings, Pomdoctor is innovating its value proposition through AI-powered chronic disease management memberships. These services leverage wearable devices to facilitate continuous health monitoring, thereby offering personalized health insights and physician-led interventions. With this model, Pomdoctor aims to enhance user engagement and establish a steady stream of subscription-based revenue, which promises higher margins than traditional transactional healthcare.

3. B2B Enterprise and Hospital Services: This tier revolves around commercializing healthcare technology and services through partnerships with enterprises, hospitals, and insurers. Pomdoctor plans to provide B2B solutions tailored to chronic disease management, remote patient monitoring, and healthcare analytics. This approach aims to broaden the reach of Pomdoctor's services by integrating its capabilities into existing frameworks used by institutions, thereby scaling operations.

4. Pharmaceutical Real-World Studies and Data Services: This tier represents a long-term strategic avenue for growth. Pomdoctor aims to curate a rich healthcare data ecosystem that draws from various interactions, including prescriptions and patient management activities. With proper data governance and privacy protocols, these insights could support pharmaceutical companies in real-world treatment evaluations and other crucial areas of healthcare decision-making.

Management Insights and Future Directions

Zhenyang Shi, Chairman and CEO of Pomdoctor, emphasized that the company will not abandon its established healthcare roots. Instead, Pomdoctor sees its existing internet hospital and pharmaceutical networks as vital to the company’s growth trajectory. The integration of AI and technology into healthcare delivery is poised to enhance operational efficiencies while fostering better patient relationships.

The evolution of Pomdoctor’s business model underscores an essential shift towards predictive healthcare, wherein data analytics and AI capabilities intersect with traditional healthcare practices. The primary goal is to improve healthcare outcomes while creating sustainable value for all stakeholders involved.

In conclusion, POMDOCTOR LIMITED stands at the forefront of digital healthcare innovation, merging technology with proven healthcare models to create a comprehensive and sustainable ecosystem. As the company continues to strengthen its healthcare operations through advanced technology, the future of patient care looks promising.